Holland Capital Invests in Curess

Amsterdam, June 20th, 2024 – Holland Capital participates in Curess, a leading organization in youth care focused on systemic family support. Through the collaboration with Holland Capital, further growth and development can be achieved.

Systemic Family Support

Curess offers specialized ambulatory youth care (such as intensive systemic guidance, ambulatory emergency help, perspective research, and co-parenting investigations) and focuses on strengthening families through practical and directly applicable assistance. Curess operates without waiting lists and can scale its operations up and down quickly, to deliver the desired care swiftly and with high quality. The organization achieves this by applying self-developed software that supports core processes (such as planning) and thus reduces administrative pressure.

Strategic Parntership

With this strategic partnership, Curess has found a partner to achieve its ambitious strategic goals.

Eddy de Bruin, CEO of Curess, states: “With the support of Holland Capital, we can realize our ambitions and help even more young people and families. With their expertise and resources, we are better equipped to significantly increase our impact in youth care. We are committed to providing the necessary support to families to learn to live together better, without waiting lists, through our dedicated professionals.”

Margot Engels, Healthcare Partner at Holland Capital, adds: “We are proud to add Curess to our portfolio. Curess provides crucial support to families in an innovative way, and we look forward to working together on their growth ambitions and further professionalization of their services. Our shared vision is to provide the best possible care and support.”

About Curess

With over 200 registered professionals, Curess offers specialized ambulatory youth care to young people and families to ensure they can live together better. By utilizing personal and innovative methods, Curess strives for a safe and supportive environment for children and their families. Curess is active in the regions of Twente, Midden-IJssel, Oost-Veluwe, Noord-Veluwe, Achterhoek, and Zuid-Drenthe

About Holland Capital

Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and strives for an open, sustainable, and professional relationship with the management teams of the companies they invest in, with the common goal of realizing growth. Holland Capital has offices in Amsterdam and Düsseldorf. With specialized sector teams, it focuses on the Healthcare, Technology, and Agrifood-Tech sectors. They understand the dynamics and opportunities, and have an extensive network in these sectors.

 The participation in Curess fits within Holland Capital’s strategy to invest in companies that contribute to societal challenges and create value for society. With this investment, Holland Capital takes an important step in further strengthening its portfolio within the healthcare sector.

LMtec Digital Solutions completes rebranding to Emixa

LMtec Digital Solutions completes rebranding to Emixa

LMtec Digital Solutions completes rebranding to Emixa Naarden, June 10th, 2024 – Our portfolio company Emixa, the leading SAP/Siemens/Mendix technology partner, is finalizing the latest phase of its rebranding to one brand. The most recent acquisition LMtec Digital...

Holland Capital invests in Hybrid Power Units & Top Systems

Holland Capital invests in Hybrid Power Units & Top Systems

Holland Capital invests in Hybrid Power Units & Top Systems   Amsterdam/Stadskanaal/Bodegraven, April 22, 2024 – Holland Capital invests in Hybrid Power Units ('HPU') and Top Systems ('TS'), both companies supply battery-based energy solutions. Holland...

The YOEP group joins forces with PHHaastrecht

The YOEP group joins forces with PHHaastrecht

The YOEP group joins forces with PHHaastrecht   Amsterdam, April 15, 2024 – Our participation the YOEP group will continue together with PHHaastrecht. By joining forces, made possible by Holland Capital, the YOEP group strengthens its youth and adult mental...

Interview with Margot Engels

Interview with Margot Engels

Investing in healthcare has pros and cons. In addition to the financial aspect, social responsibility is at least as important. Substantive knowledge of the product, the sector and market movements are therefore essential, as Margot Engels also knows.

Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411

 

Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120

Contact
info@hollandcapital.nl